These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31992246)

  • 1. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
    Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
    BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analyses of key genes and regulatory elements in fluoride-affected osteosarcoma.
    Li M; Jin X; Guo F; Wu G; Wu L; Deng S
    J Cell Biochem; 2019 Sep; 120(9):15397-15409. PubMed ID: 31037778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis.
    Shi S; Zhang L; Guo X
    Front Immunol; 2024; 15():1424950. PubMed ID: 39108264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
    Yang H; Zhao L; Zhang Y; Li FF
    Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Key mRNAs and lncRNAs in Osteosarcoma Response to Preoperative Chemotherapy with Prognostic Values.
    Li M; Cheng WT; Li H; Zhang Z; Lu XL; Deng SS; Li J; Yang CH
    Curr Med Sci; 2021 Oct; 41(5):916-929. PubMed ID: 34671904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating age‑induced differentially expressed genes and potential molecular mechanisms in osteosarcoma based on integrated bioinformatics analysis.
    Wang JS; Duan MY; Zhong YS; Li XD; Du SX; Xie P; Zheng GZ; Han JM
    Mol Med Rep; 2019 Apr; 19(4):2729-2739. PubMed ID: 30720085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration.
    Han GD; Dai J; Hui HX; Zhu J
    J Orthop Surg Res; 2023 Jun; 18(1):446. PubMed ID: 37344882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A support vector machine classifier for the prediction of osteosarcoma metastasis with high accuracy.
    He Y; Ma J; Ye X
    Int J Mol Med; 2017 Nov; 40(5):1357-1364. PubMed ID: 28901446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential key genes associated with osteosarcoma based on integrated bioinformatics analyses.
    Hu G; Cheng Z; Wu Z; Wang H
    J Cell Biochem; 2019 Aug; 120(8):13554-13561. PubMed ID: 30920023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALOX5AP is an Indicator for High CD8 Lymphocyte Infiltration and "Hot" Tumor Microenvironment in Osteosarcoma: A Bioinformatic Study.
    Chen Y; Zeng C; Zhang X; Hua Q
    Biochem Genet; 2023 Dec; 61(6):2363-2381. PubMed ID: 37041365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis.
    Wang DW; Yu SY; Cao Y; Yang L; Liu W; Er XQ; Yao GJ; Bi ZG
    Med Sci Monit; 2016 Jun; 22():2075-85. PubMed ID: 27314445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma.
    Gong Y; Wei ZR
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1522. PubMed ID: 34383385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma.
    Shi Y; He R; Zhuang Z; Ren J; Wang Z; Liu Y; Wu J; Jiang S; Wang K
    J Cell Biochem; 2020 Jul; 121(7):3479-3490. PubMed ID: 31898371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics integrated analysis to investigate candidate biomarkers and associated metabolites in osteosarcoma.
    Wang J; Gong M; Xiong Z; Zhao Y; Xing D
    J Orthop Surg Res; 2021 Jul; 16(1):432. PubMed ID: 34225733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential predictive value of immune-related genes FUCA1 and NCKAP1L for osteosarcoma metastasis.
    Wang X; Dou J; Liu M; Zhang Y; Li Y; Tong Z
    Gene; 2024 Nov; 927():148645. PubMed ID: 38844271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell Differentiation Trajectory-Associated Molecular Classification of Osteosarcoma.
    Xu A; Qian C; Lin J; Yu W; Jin J; Liu B; Tao H
    Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.
    Yang Y; Zhang Y; Qu X; Xia J; Li D; Li X; Wang Y; He Z; Li S; Zhou Y; Xie L; Yang Z
    Oncotarget; 2016 Dec; 7(52):87194-87205. PubMed ID: 27888627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.